The FDA has asked the drug makers to submit a trea
Post# of 148277
(Total Views: 721)
Posted On: 09/03/2020 5:49:14 PM
The FDA has asked the drug makers to submit a treatment plan to make the drug more widely available.
Dr. Jonathan Javitt, the CEO of NeuroRx, said, “We’re talking to people who have critical COVID-19, with respiratory failure. That is people whose lungs have been affected by the COVID virus, such that their lungs don’t send oxygen properly to their bodies. Then the drug will be available at every hospital.”
Dr. Jonathan Javitt, the CEO of NeuroRx, said, “We’re talking to people who have critical COVID-19, with respiratory failure. That is people whose lungs have been affected by the COVID virus, such that their lungs don’t send oxygen properly to their bodies. Then the drug will be available at every hospital.”
(1)
(2)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼